January 11, 2010

Erythropoiesis-Stimulating Agents — Time for a Reevaluation

.   .   

This NEJM “Perspectives” article from the Food and Drug Administration discusses the data driving a need to re-evaluate the use of ESAs in the treatment of anemia due to chronic kidney disease.

Related Articles:

Anemia, Editorial

Comments are closed.